Revista de Senologia y Patologia Mamaria, published by ELSEVIER, serves as a vital resource for researchers and practitioners in the fields of obstetrics, gynecology, oncology, and radiology. With its ISSN 0214-1582 and E-ISSN 1578-1399, the journal's scope encompasses the latest advancements and multidisciplinary approaches to breast pathology and senology. Despite its current Q4 ranking across various categories, the journal continues to contribute significantly to the academic discourse, offering a platform for rigorous peer-reviewed articles, case studies, and clinical trials. Its ongoing commitment to distributing knowledge that advances the field is essential, especially given the increasing relevance of breast health in patient care. Situated in Spain with accessible research from 2012 to 2024, the journal invites contributions that further the understanding and treatment of breast-related diseases, making it an indispensable tool for students and healthcare professionals alike, eager to enhance their expertise in this specialized area.

Current Breast Cancer Reports is a vital academic journal published by Springer that focuses on the latest research and advancements in the field of breast cancer. With its ISSN 1943-4588 and E-ISSN 1943-4596, this journal serves as an essential resource for oncologists, researchers, and healthcare professionals dedicated to improving diagnosis and treatment strategies for breast cancer. Spanning from 2009 to 2024, it provides a platform for high-quality, peer-reviewed articles that encompass a range of topics, including molecular biology, clinical trials, and innovative therapeutic approaches. Although it is currently classified in the Q3 category in Oncology and is positioned in the 29th percentile, the journal remains committed to elevating its academic impact and contributing meaningfully to the ongoing fight against breast cancer. As it seeks to disseminate critical findings and foster collaboration within the scientific community, Current Breast Cancer Reports is poised to be an indispensable tool for anyone keen on advancing the field.

Journal of Breast Imaging is an esteemed peer-reviewed journal dedicated to advancing the field of breast imaging, published by Oxford University Press. Since its inception in 2019, the journal has been instrumental in disseminating innovative research and clinical practices, contributing vital knowledge to the domains of Radiology, Nuclear Medicine, and Ultrasound Technology. Notably, it holds a respectable impact factor and is categorized in the Q2 quartile for both applicable categories, asserting its position as a significant resource within the scholarly community. With a commendable ranking of #153/333 in Radiology, and #31/63 in Radiological and Ultrasound Technology, the journal consistently showcases groundbreaking studies that influence best practices and set a benchmark for practitioners and researchers alike. Although it currently does not offer open access, the journal prioritizes high-quality research that is pivotal for understanding and enhancing breast imaging methodologies at a global level. By exploring topics that range from the latest imaging techniques to innovative diagnostic technologies, the Journal of Breast Imaging serves as a cornerstone for professionals seeking to enhance their knowledge and expertise in this vital area of health care.

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

CLINICS IN PLASTIC SURGERY is a premier journal dedicated to the field of plastic and reconstructive surgery, published by W B SAUNDERS CO-ELSEVIER INC. Renowned for its rigorous peer-review process and high-quality scholarly articles, this journal holds a prestigious Q1 quartile ranking in the Surgery category, as well as ranking #99 out of 551 in Scopus' Medicine & Surgery category, placing it in the 82nd percentile among its peers. Since its inception in 1974, the journal has provided a vital platform for the dissemination of cutting-edge research, clinical practices, and advancements in plastic surgery, catering to the interests of researchers, healthcare professionals, and students alike. Although it does not offer open access options, its content remains invaluable to those seeking to enhance their knowledge and stay informed about the latest developments in the field. With a commitment to excellence and an expansive scope, CLINICS IN PLASTIC SURGERY continues to play a crucial role in the education and advancement of surgical practitioners around the globe.

The International Journal of Breast Cancer is a premier academic platform dedicated to advancing the field of breast cancer research and treatment. Published by HINDAWI LTD, this journal embraces an Open Access model since 2011, ensuring that cutting-edge research is readily accessible to all, facilitating the dissemination of knowledge across the global scientific community. With its ISSN 2090-3170 and E-ISSN 2090-3189, the journal caters to a diverse audience comprising researchers, clinicians, and students engaged in oncology and pharmacology. The journal has consistently demonstrated its relevance, classified in the Q4 quartile for Cancer Research and the Q3 quartile for both Oncology and Pharmacology in the latest rankings. It currently ranks #151/272 in the Medicine & Pharmacology category and #232/404 in Medicine & Oncology according to Scopus, showcasing its adaptive role in an evolving field. Commencing in 2013 and continuing through to 2024, the journal is positioned to be an essential resource, addressing critical topics and fostering innovative solutions for breast cancer challenges.

Current Problems in Cancer: Case Reports is a prominent scholarly journal published by Elsevier, focusing on critical case reports within the field of oncology. Since its transition to Open Access in 2020, it has enhanced accessibility for researchers and healthcare professionals seeking to share and discuss unique clinical scenarios and insights that advance cancer treatment and patient care. Operating from the United States, this journal aims to address the important and often intricate challenges faced in oncology, facilitating a platform for knowledge exchange and the exploration of new perspectives in cancer management. Despite its current Q4 category ranking in the 2023 oncology category of Scopus with a rank of #359/404, its goal is to enrich the academic discourse by featuring diverse case reports and promoting evidence-based practices. As the journal evolves from 2021 to 2024, it seeks to impact the field by inviting researchers, professionals, and students to contribute their findings, ultimately fostering a collaborative environment for tackling the complexities of cancer.

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

BREAST CANCER RESEARCH, published by BMC, is a prestigious open-access journal dedicated to advancing the field of oncology with a specific focus on breast cancer. Since its inception in 1999, the journal has established itself as a leading platform for disseminating high-quality research, with an impressive impact factor and recognition in the Q1 category for both Cancer Research and Oncology as of 2023. The journal is ranked 45th out of 404 in the field of Medicine _ Oncology and 37th out of 230 in Biochemistry, Genetics and Molecular Biology _ Cancer Research, placing it in the top echelons of research quality and relevance at 88th and 84th percentiles, respectively. BREAST CANCER RESEARCH is committed to facilitating rapid and open access to groundbreaking findings, making it an invaluable resource for researchers, healthcare professionals, and students striving to enhance their understanding of breast cancer mechanisms, treatments, and prevention strategies. With its base in the United Kingdom, the journal continues to foster international collaborations and discussions aimed at improving patient outcomes and enriching cancer research worldwide.